Freedom Wealth Alliance’s MetLife MET Stock Holding History

Freedom Wealth Alliance’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-113	Closed	-$8.18K	–	294
2022 Q4	$8.18K	Buy	+113	New	+$8.09K	0.01%	308

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Freedom Wealth Alliance's MET Position: Q1 2023 in Review

Freedom Wealth Alliance sold out of MetLife (MET) in Q1 2023, closing a stake of 113 shares — an estimated $8.18K sold.

Freedom Wealth Alliance first reported a position in MET in Q4 2022 and held it in 1 quarter. The position peaked at $8.18K in Q4 2022. 1,211 funds tracked by Wall St. Rank hold MET as of Q1 2023.

Freedom Wealth Alliance reported no remaining MetLife position as of Q1 2023 after selling out during the quarter.
Freedom Wealth Alliance sold 113 MetLife shares in Q1 2023, an estimated $8.18K.
Freedom Wealth Alliance first reported a position in MetLife in Q4 2022 and held it in 1 quarter.
Freedom Wealth Alliance's MetLife position peaked at $8.18K in Q4 2022.
1,211 funds tracked by Wall St. Rank held MetLife as of Q1 2023.

Based on Freedom Wealth Alliance's 13F filing for Q1 2023, filed 25 Apr 2023.